Next |
home / stock / nbrv / nbrv message board
Subject | By | Source | When |
---|---|---|---|
when nobody wants this...its will squeeze after they | TheFinalCD | investorshub | 09/22/2022 5:25:56 PM |
MM fake out! | subslover | investorshub | 09/22/2022 4:42:20 PM |
i dont doubt it now | TheFinalCD | investorshub | 09/22/2022 4:35:53 PM |
2.31 low is like .09cent pre-split meanwhile | TheFinalCD | investorshub | 09/22/2022 4:35:15 PM |
3.70= .14 prw-splif this was .36 yesterday on | TheFinalCD | investorshub | 09/16/2022 10:08:07 PM |
MEMX & ARCX short $NBRV | TheFinalCD | investorshub | 09/16/2022 3:45:58 PM |
yes NEWS could send it to Pluto to | TheFinalCD | investorshub | 09/16/2022 2:30:13 PM |
LOL! You never know, what if they put | subslover | investorshub | 09/16/2022 1:59:01 PM |
$NBRV has the ability to break below a | ErnieBilco | investorshub | 09/16/2022 1:49:31 PM |
dog with fleas | TheFinalCD | investorshub | 09/16/2022 1:45:57 PM |
5.87 with 7.19 hi and 5.25 low | TheFinalCD | investorshub | 09/16/2022 11:56:25 AM |
I must be seeing things! I better get | subslover | investorshub | 09/16/2022 10:24:41 AM |
yesterday .30 is equal to 7.50 today | TheFinalCD | investorshub | 09/16/2022 8:50:29 AM |
now 6.25 with 6.99 high and 5,25 low | TheFinalCD | investorshub | 09/16/2022 8:39:55 AM |
the tricky part is when brokers have shares | TheFinalCD | investorshub | 09/16/2022 4:14:01 AM |
znewcar1: NBRV 40% v101M c.2671 f66,5M H.338 PMH.36 | znewcar1 | investorshangout | 09/15/2022 8:45:17 PM |
look at what$ NBRV NBRO CLBS$ LSTA $ADTX | TheFinalCD | investorshub | 09/15/2022 7:57:28 PM |
took advantage of the dip filled .241 and | TheFinalCD | investorshub | 09/15/2022 7:46:13 PM |
$NBRV is a total loss - never gonna | ErnieBilco | investorshub | 09/15/2022 2:45:04 PM |
$NBRV .25'S here | TheFinalCD | investorshub | 09/15/2022 2:29:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Nabriva Therapeutics plc Company Name:
NBRV Stock Symbol:
NASDAQ Market:
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment ...
- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Na...
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, ...